Oral Fluid Drug Testing: The Pros Far Outweigh the Cons

on April 21, 2026

Brian Feeley, Vice President

Oral Fluid Drug Testing: The Pros Far Outweigh the Cons

This information is provided for educational purposes only. Reader retains full responsibility for the use of the information contained herein.

While oral fluid drug testing currently represents a minority of all workplace drug tests conducted in the United States, interest in oral fluid has been increasing since the release of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Mandatory Guidelines for Oral Fluid Testing (OFMG) in 2019. This was further bolstered when the U.S. Department of Transportation (DOT) announced its allowance of lab-based oral fluid drug testing for covered agencies in 2023. While we are still waiting for two laboratories to be certified by the Department of Health and Human Services (HHS) for testing to officially begin, my crystal ball tells me we are getting closer.

Current Consulting Group’s (CCG) annual 2026 Drug Testing Industry Survey, 71% of providers surveyed said they offer lab-based oral fluid testing and 54% said they offer POCT or rapid-result oral fluid testing. Additionally, when asked what drug testing methods they intend to add in the next 12 months, 22% said lab-based oral fluid testing and 23% said oral fluid POCT. In years past, these percentages were far more in favor of urine testing, the only method approved by SAMHSA and DOT since the late 1980s.

The following is a brief list of the perceived pros and cons of oral fluid drug testing.

Advantages

Accuracy — “Oral fluid [drug testing] provides the same scientific and forensic supportability of drug test results as the Mandatory Guidelines for Federal Workplace Drug Testing Programs using urine.”[i]
Collections — May be conducted onsite in the workplace by non-professional collectors, at a collection site, or in a laboratory setting. If needed, is available online, and collectors can begin collecting immediately after training.
Offers flexibility — Samples can be collected anytime, anywhere, and oral fluid drug testing can be implemented in combination with urine drug testing or other methods best suited for your program.
Shy bladder — Eliminates intentional and unintentional shy bladder issues that slow down the testing process and keep existing employees away from work longer, resulting in lost time and money.
Recent use detection – The detection of drugs in oral fluid occurs almost immediately after use, and drugs do not remain in oral fluid for extended periods of time, as they do with urine testing. This makes oral fluid an ideal specimen for detecting very recent use, such as use immediately prior to or during the workday.
Drug test cheating — Every oral fluid collection, if conducted properly, is 100% observed, eliminating most, if not all, traditional drug test cheating methods.
Similar positive rates compared to urine screening — Oral fluid cutoffs used for screening samples have been set at levels that yield very similar positive rates to urine testing.[ii] And now that SAMHSA has specified the cutoffs for lab-based oral fluid testing, all certified laboratories conducting oral fluid testing will be required to use these standardized cutoffs, keeping the playing field level for all those conducting and using oral fluid testing.
Gender-related collector issues are eliminated — Because oral fluid collections do not require a donor to use a bathroom, collector and donor gender is not a concern, as it is with observed urine collections.
Legally defensible — Lab-based oral fluid testing technology is reliable and accurate, making it legally defensible at the same level as lab-based urine testing. Oral fluid testing is currently legal in 48 states, and lab-based oral fluid testing has been upheld in the judicial system in most instances.
Legal marijuana-friendly — With the onset of new legal marijuana laws, employers are increasingly pressed to identify only recent use of marijuana. Some states, such as California and Washington, even require employers to use drug testing methods that detect only the parent, or psychoactive, form of marijuana/THC and NOT the metabolite, which is detected using urine screening. Oral fluid testing detects the parent or psychoactive form of THC, making it an ideal solution for use in those states and others that may impose similar laws in the future.
Time savings — On-site collections significantly reduce time away from work for both the donor and supervisor, improving productivity. Additionally, on-site collections eliminate the collection costs incurred when using outside sites.[iii]
More union-friendly — Unions have historically favored oral fluid testing because of its shorter window of detection and the less-invasive nature of the collection process.

Challenges

Certified laboratories — Currently, there are no laboratories certified to perform federally regulated oral fluid tests; however, this is expected to change soon, as several labs are currently undergoing the HHS testing and certification process.
Collectors — Prior to the OFMG, there were no federal standards for the collection of oral fluid samples. Although oral fluid collections are much less complicated than urine collections, someone certified to collect urine samples is not automatically qualified to collect oral fluid samples. The new regulations require qualified collectors to receive appropriate training, including training on the proper use of any oral fluid collection device in accordance with each manufacturer’s standards. This process is already underway in 2026, with one device that appears to be compliant with SAMHSA requirements.
Inventory — Providers and end users must maintain an inventory of devices either at workplaces or at offsite collection facilities, depending on where collections will take place and who will conduct them. For employers, this may add a level of complexity to the drug testing process.
Not widely understood — Surprisingly, some individuals are still not familiar with the science behind oral fluid testing. As such, adoption has been slower than expected, although SAMHSA projects “…a transition rate of 7% the first year after the implementation period and 25-30% by year four.”[iv]
Panel options – Oral fluid testing does not offer as many or as broad panel variations as urine testing. Companies that require medical professional panels may not be able to mirror expanded panels with oral fluid testing initially, but it is likely that this will become an option as oral fluid becomes more widely adopted.
State laws are complicated — Lab-based oral fluid testing is currently not permitted in two states, while eight states require compliance, in whole or in part, with federal regulations, and additional states recommend federal compliance. Additionally, many industry-specific laws require federal compliance. With the release of the OFMG, these states’ laws will presumably permit lab-based oral fluid testing, if not already allowed due to federal compliance carve-outs.
Window of detection — As stated above, oral fluid has a shorter window of detection compared to urine—hours versus days. Some employers will continue to prefer a wider detection window.

Conclusion

Clearly, with SAMHSA’s release of the OFMG and the new DOT rules, lab-based oral fluid testing is entering a new era, one that is likely to result in a significantly larger share of the workplace drug testing market. SAMHSA’s decision to develop the OFMG and permit federal employers (and soon, DOT-covered employers) to use this technology is the biggest development in the drug testing industry since the original release of the government’s mandatory guidelines in 1988.

It is also worth noting that we are seeing more and more companies combining drug testing methods with the goal of utilizing the best test methods for the application or reason for testing. As an example, in the same 2026 CCG industry survey mentioned above, providers were asked, “Do you have customers who use more than one drug testing method?” Sixty-six percent said they have customers who combine urine and oral fluid testing. This clearly demonstrates that customers believe one size (urine testing) does not need to fit all anymore.

While it is true that lab-based and rapid/instant oral fluid testing will not replace urine testing, it clearly possesses many advantages that make it ideally suited to align with the cultural and regulatory changes occurring in society today—widespread marijuana legalization and the drug testing limitations being legislatively imposed upon employers in certain jurisdictions. It is safe to say that oral fluid testing is here to stay.

Is your drug testing program prepared for the growing shift toward oral fluid testing? As regulations evolve and more employers adopt flexible testing strategies, now is the time to evaluate whether oral fluid testing belongs in your workplace program. Contact Current Consulting Group (CCG) today to learn how oral fluid testing can fit your compliance needs, improve efficiency, and help future-proof your testing strategy.

About the author: Brian Feeley spent 26 years at OraSure Technologies, where he was a senior manager involved in the development, launch, and implementation of the first FDA-cleared, laboratory-based oral fluid drug testing products (Intercept). Working with laboratory and TPA partners, Brian and his team introduced oral fluid drug testing to some of the largest retailers, manufacturers, and other commercial entities in the U.S. in the early 2000s. In the earlier part of his career, Brian also worked in the laboratory, developing drug tests and gaining firsthand experience with the technical specifications and importance of assay performance.

Copyright © 2010-2026 The Current Consulting Group, LLC – No portion of this article may be reproduced, retransmitted, posted on a website, or used in any manner without the written consent of the Current Consulting Group, LLC. When permission is granted to reproduce this article in any way, full attribution to the author and copyright holder is required.

[i] “Mandatory Guidelines for Federal Workplace Drug Testing Programs – Oral/Fluid.” Department of Health and Human Services, The Federal Register Vol. 84 No. 207, 25 Oct. 2019.

[ii] The 2024 Quest Diagnostics Drug Testing Index reported 8.4 million urine drug tests in 2023 versus 1.3 million oral fluid drug tests in the same time. “Quest Diagnostics Drug Testing Index: Full year 2023 tables.” Quest Diagnostics, published 09/27/24, https://www.questdiagnostics.com/business-solutions/employers/drug-screening/knowledge-center/drug-testing-index.

[iii] “Mandatory Guidelines for Federal Workplace Drug Testing Programs – Oral/Fluid.” Department of Health and Human Services, The Federal Register Vol. 84 No. 207, 25 Oct. 2019.

[iv] “Mandatory Guidelines for Federal Workplace Drug Testing Programs – Oral/Fluid.” Department of Health and Human Services, The Federal Register Vol. 84 No. 207, 25 Oct. 2019.